{"entity":{"id":"infinity-pharmaceuticals","kind":"company","name":"Infinity Pharmaceuticals","aka":["Infinity Pharmaceuticals, Inc.","Infinity"],"tldr":"Infinity was the Cambridge biotech that discovered duvelisib, the PI3K-delta/gamma inhibitor later approved for chronic lymphocytic leukaemia, before licensing it out and turning to eganelisib; it filed for bankruptcy in 2023.","summary":"Infinity Pharmaceuticals, founded in 2001 in Cambridge, Massachusetts, developed duvelisib (IPI-145) through the phase 3 DUO trial in relapsed chronic lymphocytic leukaemia before licensing it to Verastem, which won approval in 2018. Its later PI3K-gamma inhibitor eganelisib reached phase 2 in combination with checkpoint inhibitors, and the company filed for bankruptcy in 2023. Its trials remain on ClinicalTrials.gov under Infinity as lead sponsor.","asOf":"2026-09-11","links":[{"label":"Official website","url":"http://www.infi.com"},{"label":"ClinicalTrials.gov: trials led by Infinity Pharmaceuticals, Inc.","url":"https://clinicaltrials.gov/search?lead=Infinity%20Pharmaceuticals%2C%20Inc."},{"label":"Wikidata","url":"https://www.wikidata.org/wiki/Q30296176"}],"tags":["ctgov-sponsor"],"related":[],"cancers":["cll"],"sections":[],"technologies":[],"targets":[],"drugs":["duvelisib"],"companies":[],"institutions":[],"pathways":[],"terms":["pivotal-trial","clinical-trial"],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"Cambridge, MA","country":"US","companyType":"biotech","website":"http://www.infi.com","founded":2001,"stage":"defunct","investors":[],"funding":[]},"route":"/companies/infinity-pharmaceuticals/","neighbours":{"cancer":[{"id":"cll","kind":"cancer","name":"Chronic lymphocytic leukaemia","route":"/cancers/cll/"}],"drug":[{"id":"duvelisib","kind":"drug","name":"Duvelisib","route":"/drugs/duvelisib/"}],"term":[{"id":"clinical-trial","kind":"term","name":"Clinical trial","route":"/terms/clinical-trial/"},{"id":"pivotal-trial","kind":"term","name":"Pivotal (registrational) trial","route":"/terms/pivotal-trial/"}]}}